Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Debt Ratio: 2020-2023

Historic Debt Ratio for C4 Therapeutics (CCCC) over the last 2 years, with Jun 2023 value amounting to 0.03.

  • C4 Therapeutics' Debt Ratio rose 22.03% to 0.03 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.03, marking a year-over-year increase of 22.03%. This contributed to the annual value of 0.03 for FY2022, which is 25.42% up from last year.
  • According to the latest figures from Q2 2023, C4 Therapeutics' Debt Ratio is 0.03, which was up 0.06% from 0.03 recorded in Q1 2023.
  • In the past 5 years, C4 Therapeutics' Debt Ratio registered a high of 0.04 during Q3 2020, and its lowest value of 0.02 during Q2 2021.
  • In the last 3 years, C4 Therapeutics' Debt Ratio had a median value of 0.02 in 2022 and averaged 0.02.
  • In the last 5 years, C4 Therapeutics' Debt Ratio tumbled by 51.64% in 2021 and then rose by 29.73% in 2023.
  • C4 Therapeutics' Debt Ratio (Quarterly) stood at 0.03 in 2020, then declined by 15.42% to 0.02 in 2021, then grew by 25.42% to 0.03 in 2022, then increased by 22.03% to 0.03 in 2023.
  • Its Debt Ratio was 0.03 in Q2 2023, compared to 0.03 in Q1 2023 and 0.03 in Q4 2022.